Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector

Zhixiong Li1, Maike Schwieger, Claudia Lange

  • 1Experimental Cell Therapy, Department of Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

Experimental Hematology
|December 10, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies.

Haematologica·2026
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

A new therapeutic frontier: CD19-targeting CAR-T cell therapy in rheumatoid arthritis: a concise report.

Rheumatology (Oxford, England)·2026
Same author

Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastoma.

Molecular therapy. Oncology·2026
Same author

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.

Cell death discovery·2026

This study introduces a reliable retroviral transduction protocol for hematopoietic stem cells (HSC), improving gene transfer efficiency and clinical applicability for gene therapy research.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Hematology

Background:

  • Current retroviral gene transfer protocols for murine hematopoietic stem cells (HSC) exhibit variable efficiency and use non-clinical methods.
  • Developing clinically relevant and efficient gene transfer methods is crucial for advancing gene therapy.

Purpose of the Study:

  • To develop and evaluate a reliable retroviral transduction protocol for murine HSC that aligns with clinical methodologies.
  • To enhance gene transfer efficiency and reproducibility in HSC for preclinical studies.

Main Methods:

  • Enrichment of HSC from bone marrow via magnetic cell sorting (lineage depletion).
  • Culture of HSC in serum-free medium with an optimized growth factor cocktail.
  • Utilized cell-free retroviral vector particles preloaded on coated plates to minimize serum contamination.

Related Experiment Videos

Main Results:

  • Achieved high gene marking rates in cultured mononuclear cells (53.7%) and stem/progenitor cells (69.8%) after two infection rounds.
  • Demonstrated efficient gene transfer (31.2%) even after a single round of infection.
  • Exhibited high reproducibility, controlled gene dosage ( < 3 transgene copies), and successful coinfection capability.

Conclusions:

  • The developed protocol enables efficient retroviral transduction of murine bone marrow repopulating cells with defined gene dosage.
  • This method minimizes procedures that reduce stem cell output and repopulating capacity.
  • The protocol can enhance the predictive value of preclinical studies for gene therapy interventions.